TFF Pharmaceuticals, Inc. (TFFP)
Dec 13, 2024 - TFFP was delisted (reason: winding down operations)
0.0650
-0.0977 (-60.05%)
Inactive · Last trade price on Dec 12, 2024

TFF Pharmaceuticals Stock Forecast

TFFP's stock price has decreased by -99.21% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for TFF Pharmaceuticals stock has a target of 44, which predicts a 67,592.31% increase from the current stock price of 0.07.

Price Target: $44.00 (+67,592.31%)
Analyst Consensus: Strong Buy
No price target forecast data available
TargetLowAverageMedianHigh
Price$44$44$44$44
Change+67592.3%+67592.3%+67592.3%+67592.3%
* Price targets were last updated on Mar 28, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for TFF Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy222221
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total222221

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Roth MKM
Roth MKM
Strong Buy
Maintains
$56$44
Strong BuyMaintains$56$44+67,592.31%Mar 28, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$550$100
Strong BuyMaintains$550$100+153,746.15%May 25, 2023
JonesTrading
JonesTrading
Strong Buy
Initiates
$175
Strong BuyInitiates$175+269,130.77%Mar 22, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$550
Strong BuyReiterates$550+846,053.85%Mar 17, 2023
B. Riley Securities
B. Riley Securities
Strong Buy
Maintains
$600$450
Strong BuyMaintains$600$450+692,207.69%Mar 29, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
1.18M
from 733.87K
Increased by 60.25%
Revenue Next Year
816.00K
from 1.18M
Decreased by -30.61%
EPS This Year
-4.37
from -11.85
EPS Next Year
-3.85
from -4.37
Fiscal YearFY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
--88.16K495.81K733.87K1.18M816.00K11.96M
Revenue Growth
---462.39%48.02%60.25%-30.61%1,365.93%
EPS
-132.79-22.73-31.26-26.49-11.85-4.37-3.85-2.76
EPS Growth
--------
Forward PE
--------
No. Analysts
-----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202420252026
High1.2M840,00012.3M
Avg1.2M816,00012.0M
Low1.1M784,00011.5M

Revenue Growth

Revenue Growth202420252026
High
65.0%
-28.6%
1,408.9%
Avg
60.2%
-30.6%
1,365.9%
Low
54.0%
-33.3%
1,308.3%

EPS Forecast

EPS202420252026
High-4.49-3.96-2.85
Avg-4.37-3.85-2.76
Low-4.19-3.69-2.66

EPS Growth

EPS Growth202420252026
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.